Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Harold J Burstein
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
368 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Arroyo Grande Community
Arroyo Grande, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- El Camino Hospital
Mountain View, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Valley Care Health System - Pleasanton
Pleasanton, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Salinas Valley Memorial
Salinas, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Zuckerberg San Francisco General Hospital
San Francisco, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Northbay Cancer Center
Vacaville, California, United States
- Uchealth Memorial Hospital Central
Colorado Springs, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Saint Vincent'S Medical Center
Bridgeport, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut, United States
- Harold Leever Regional Cancer Center
Waterbury, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Sept 2006
- Primary completion
- 1 Jul 2014
- Completion
- 2 Jul 2014
- Last update posted
- 20 Dec 2019
- Registered enrollment
- 295
- Registry id
- NCT00390455
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.